Cargando…
A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma
Glioblastoma (GBM) is an aggressive malignancy with limited effectiveness of standard of care therapies including surgery, radiation, and temozolomide chemotherapy necessitating novel therapeutics. Unfortunately, GBMs also harbor several signaling alterations that protect them from traditional thera...
Autores principales: | Eustace, Nicholas J., Anderson, Joshua C., Warram, Jason M., Widden, Hayley N., Pedersen, Rune T., Alrefai, Hasan, Patel, Zeel, Hicks, Patricia H., Placzek, William J., Gillespie, G. Yancey, Hjelmeland, Anita B., Willey, Christopher D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885995/ https://www.ncbi.nlm.nih.gov/pubmed/33077834 http://dx.doi.org/10.1038/s41388-020-01511-9 |
Ejemplares similares
-
MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell lines
por: Rohrbach, Timothy D., et al.
Publicado: (2017) -
13109 Phosphorylation state of Myristoylated Alanine-Rich C-Kinase Substrate Effector Domain mimetics determines its cytotoxicity in glioblastoma and macrophage model
por: Alrefai, Hasan, et al.
Publicado: (2021) -
Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma
por: Eustace, Nicholas J., et al.
Publicado: (2019) -
The multiple mechanisms of MCL1 in the regulation of cell fate
por: Widden, Hayley, et al.
Publicado: (2021) -
MARCKS and MARCKS-like proteins in development and regeneration
por: El Amri, Mohamed, et al.
Publicado: (2018)